abstract |
Disclosed is the use of sodium meta-arsenite (AsO2-) for the manufacture of a pharmaceutical composition for the treatment of a solid malignancy chosen from the group consisting of colon tumour, gastric tumour, mammary tumour, ovarian tumour, prostate tumour and renal tumour. |